Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Cannabis and the Liver: Update for the Hepatologist

    Product not yet rated Contains 2 Component(s) Recorded On: 12/12/2019

    Webinar hosted by the Clinical Practice Special Interest Group on December 12, 2019.

    Use of cannabis is growing in the population with increased interest in potential medicinal use as well as recreational use depending on the jurisdiction. Given this, clinicians need to have an understanding about cannabis and its potential impacts on liver disease. This webinar will provide attendees information about cannabis, its major components (THC/CBD) as well as discuss potential policy implications regarding transplantation. As well, the literature regarding safety and potential benefits/harms will be reviewed in detail. We will utilize a live webinar format that will be recorded for on-demand viewing on LiverLearning®.

    Stephen Congly (Moderator)

    Dr. Stephen Congly is a Clinical Assistant Professor at the University of Calgary in the Division of Gastroenterology and Hepatology with a practice consisting of both general and transplant hepatology. He completed his internal medicine and gastroenterology training at the University of Calgary and subsequently a fellowship in Hepatology at the University of Calgary and in Transplant Hepatology at Mayo Clinic, Rochester, MN.

    He has a Master of Science in Health Economics, Policy and Management from the London School of Economics and is a member of the O'Brien Institute for Public Health at the University of Calgary. His research interests include health technology assessment, resource utilization, hepatocellular carcinoma and liver transplantation.

    Kevork Peltekian

    Dr. Peltekian is the head of Division of Digestive Care and Endoscopy at the Queen Elizabeth II Health Sciences Centre and Professor of Medicine and Surgery at Dalhousie University. Since 1995, he has been practicing as a specialist in liver disease and transplantation in Nova Scotia. Over the years, Dr. Peltekian has been frequently recognized for excellence in undergraduate and postgraduate education as well as research. He has over 80 peer-reviewed publications in high impact journals. Over the years, he has held major leadership roles with Chairman and Chief Executive Officer of the Canadian Liver Foundation 2005-2009 and President of the Canadian Association for Study of Liver 2012-2014.

    For his volunteer work and contributions to the fight against liver disease, Dr. Peltekian was awarded the Queen Elizabeth II Diamond Jubilee Medal. In 2017, Dr. Peltekian received the CASL Distinguished Service Award for his significant contributions to the practice of Hepatology in Canada. He has been a member of AASLD since 1993.

  • NAFLD Debrief

    Contains 2 Component(s) Recorded On: 11/12/2019

    NAFLD Debrief presented at The Liver Meeting® 2019.

    Review key highlights from all the exciting clinical research presented at The Liver Meeting® 2019.

    Kathleen E. Corey

  • Hepatitis Debrief

    Contains 2 Component(s) Recorded On: 11/12/2019

    Hepatitis Debrief presented at The Liver Meeting® 2019.

    Digest a debrief of the newest data on the treatment of viral hepatitis presented at The Liver Meeting.

    Marc G. Ghany

  • Clinical Hepatology Debrief

    Contains 2 Component(s) Recorded On: 11/12/2019

    Clinical Hepatology Debrief presented at The Liver Meeting® 2019.

    Review a condensed summary of the clinical research highlights from The Liver Meeting.

    Michael R. Charlton

  • Leon Schiff State-of-the-Art Lecture: Molecular Pathogenesis and Management of Hepatocellular Carcinoma

    Contains 2 Component(s) Recorded On: 11/12/2019

    Leon Schiff State-of-the-Art Lecture: Molecular Pathogenesis and Management of Hepatocellular Carcinoma presented at The Liver Meeting® 2019.

    At the 2019 Leon Schiff State-of-the-Art Lecture, our selected speaker will provide a thorough overview of the advances in knowledge of the pathogenesis of hepatocellular carcinoma (HCC). The lecture will explore current data on evidence-based treatment of this disease, including novel molecular therapies and advances in precision oncology.

    David Kaplan
    Josep Llovet

  • The Liver Meeting® 2019

    Contains 39 Product(s)

    View on-demand presentations from The Liver Meeting® 2019.

    View on-demand presentations from The Liver Meeting® 2019 in Boston. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics. 

  • Advances for Practitioners: New AASLD Guidelines: Updated Recommendations and Ongoing Challenges in HCC, PBC and ALD

    Contains 4 Component(s) Recorded On: 11/11/2019

    Advances for Practitioners: New AASLD Guidelines: Updated Recommendations and Ongoing Challenges in HCC, PBC and ALD presented at The Liver Meeting® 2019.

    AASLD Guideline/Guidance Statements on treating hepatocellular carcinoma (HCC), primary biliary cholangitis (PBC) and alcohol-related liver disease (ALD) are now updated to reflect data published since 2010, when the previous versions were released. At this session, the guidelines’ authors will highlight important changes hepatologists should know and discuss controversial or challenging issues in treating patients with these chronic liver diseases.

    Julie Heimbach
    Keith D. Lindor
    Michael R. Lucey

  • Emerging Trends Symposium: Microelimination of Viral Hepatitis

    Product not yet rated Contains 7 Component(s) Recorded On: 11/11/2019

    Emerging Trends Symposium: Microelimination of Viral Hepatitis – Positive Use in Organ Transplantation presented at The Liver Meeting® 2019.

    HCV-infected organs are now being used for transplantation to HCV-uninfected recipients. This program will review existing data on both liver and non-liver transplantation from HCV-positive donors to HCV-negative recipients and key ethical and practical issues related to HCV-infected donor organs, including whether this should be done only in clinical trials or could be accepted as standard of care.

    Emily Blumberg
    Christine Durand
    Jordan J. Feld
    Paul Yien Kwo
    Susanna Naggie
    Norah Terrault

  • Global Forum: Alcohol-related Liver Disease: Seeking Local Solutions to A Global Problem

    Product not yet rated Contains 7 Component(s) Recorded On: 11/11/2019

    Global Forum: Alcohol-related Liver Disease: Seeking Local Solutions to A Global Problem presented at The Liver Meeting® 2019.

    Harmful alcohol use accounts for three million annual global deaths. Experts discuss the global health burden of alcohol-related liver disease (ALD), reporting on ALD’s impact in Africa, Latin America and Asia, region-specific factors that promote or hinder solutions and how forthcoming AASLD guidance on ALD may serve as a template to implement effective prevention and treatment strategies worldwide.

    Juan Arab
    Sumeet Asrani
    Helena Cortez-Pinto
    Hailemichael Desalegn Mekonnen
    Michael Lucey
    Jessica Mellinger
    K Rajender Reddy
    Shiv Kumar Sarin

  • Hans Popper Basic Science State-of-the-Art Lecture: Distributed Hepatocytes in Liver Homeostasis and Regeneration

    Contains 2 Component(s) Recorded On: 11/11/2019

    Hans Popper Basic Science State-of-the-Art Lecture: Distributed Hepatocytes in Liver Homeostasis and Regeneration presented at The Liver Meeting® 2019.

    The annual Hans Popper Lecture clarifies exciting new findings on cellular renewal mechanisms in liver disease and liver cancer. A subset of hepatocytes with high levels of telomerase are distributed throughout the liver lobule, serving to renew the organ during homeostasis and in response to injury. Learn how genetic ablation of these hepatocytes results in scarring and defective regenrative responses.

    Steven Artandi
    Adrian Di Bisceglie